Diatheva is an Italian biotech CDMO founded in 2002 as a spin-off from the University of Urbino, specializing in small-scale GMP manufacturing of biotechnological products for third parties. They offer contract development and production of monoclonal antibodies, polyclonal antibodies, antibody fragments, recombinant proteins, enzymes, and antigens, with AIFA-authorized GMP facilities since 2006 for biomolecules and since 2023 for medicinal products.
monoclonal antibodies, recombinant proteins, antibody fragments, diagnostic assays, small-scale biotech GMP
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.